Effect of Thuja occidentalis and its polysaccharide on cell-mediated immune responses and cytokine levels of metastatic tumor-bearing animals

References

• Albini A, Melchiori A, Santi L, Liotta LA, Brown PD, Stetler-Stevenson WG. (1991). Tumor cell invasion inhibited by TIMP-2. J Natl Cancer Inst, 83, 775–779.
   PubMed Web of Science ®Google Scholar
• Asano Y, Kaneda K, Hiragushi J, Tsuchida T, Higashino K. (1997). The tumor-bearing state induces augmented responses of organ-associated lymphocytes to high-dose interleukin-2 therapy in mice. Cancer Immunol Immunother, 45, 63–70.
   PubMed Web of Science ®Google Scholar
• Bodinet C, Lindequist U, Teuscher E, Freudenstein J. (2002). Effect of an orally applied herbal immunomodulator on cytokine induction and antibody response in normal and immunosuppressed mice. Phytomedicine, 9, 606–613.
   PubMed Web of Science ®Google Scholar
• Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV. (2002). The causal relation between human papillomavirus and cervical cancer. J Clin Pathol, 55, 244–265.
   PubMed Web of Science ®Google Scholar
• Budhu A, Wang XW. (2006). The role of cytokines in hepatocellular carcinoma. J Leukoc Biol, 80, 1197–1213.
   PubMed Web of Science ®Google Scholar
• Chintalwar G, Jain A, Sipahimalani A, Banerji A, Sumariwalla P, Ramakrishnan R, Sainis K. (1999). An immunologically active arabinogalactan from Tinospora cordifolia. Phytochemistry, 52, 1089–1093.
   PubMed Web of Science ®Google Scholar
• Cho D, Campana D. (2009). Expansion and activation of natural killer cells for cancer immunotherapy. Korean J Lab Med, 29, 89–96.
   PubMedGoogle Scholar
• Chuang MJ, Sun KH, Tang SJ, Deng MW, Wu YH, Sung JS, Cha TL, Sun GH. (2008). Tumor-derived tumor necrosis factor-alpha promotes progression and epithelial-mesenchymal transition in renal cell carcinoma cells. Cancer Sci, 99, 905–913.
   PubMed Web of Science ®Google Scholar
• Cooper MA, Fehniger TA, Caligiuri MA. (2001). The biology of human natural killer-cell subsets. Trends Immunol, 22, 633–640.
   PubMed Web of Science ®Google Scholar
• Gomez DE, Alonso DF, Yoshiji H, Thorgeirsson UP. (1997). Tissue inhibitors of metalloproteinases: Structure, regulation and biological functions. Eur J Cell Biol, 74, 111–122.
   PubMed Web of Science ®Google Scholar
• Haque E, Baral R. (2006). Neem (Azadirachta indica) leaf preparation induces prophylactic growth inhibition of murine Ehrlich carcinoma in Swiss and C57BL/6 mice by activation of NK cells and NK-T cells. Immunobiology, 211, 721–731.
   Google Scholar
• Jiang Y, Goldberg ID, Shi YE. (2002). Complex roles of tissue inhibitors of metalloproteinases in cancer. Oncogene, 21, 2245–2252.
   PubMed Web of Science ®Google Scholar
• Kägi D, Ledermann B, Bürki K, Zinkernagel RM, Hengartner H. (1996). Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu Rev Immunol, 14, 207–232.
   PubMed Web of Science ®Google Scholar
• Kelly JM, Takeda K, Darcy PK, Yagita H, Smyth MJ. (2002). A role for IFN-gamma in primary and secondary immunity generated by NK cell-sensitive tumor-expressing CD80 in vivo. J Immunol, 168, 4472–4479.
   PubMed Web of Science ®Google Scholar
• Kim HW, Chew BP, Wong TS, Park JS, Weng BB, Byrne KM, Hayek MG, Reinhart GA. (2000). Dietary lutein stimulates immune response in the canine. Vet Immunol Immunopathol, 74, 315–327.
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Aso H, Ishida N, Maeda H, Schmitt DA, Pollard RB, Suzuki F. (1992). Preventive effect of a synthetic immunomodulator, 2-carboxyethylgermanium sesquioxide, on the generation of suppressor macrophages in mice immunized with allogeneic lymphocytes. Immunopharmacol Immunotoxicol, 14, 841–864.
   PubMed Web of Science ®Google Scholar
• Lázár-Molnár E, Hegyesi H, Tóth S, Falus A. (2000). Autocrine and paracrine regulation by cytokines and growth factors in melanoma. Cytokine, 12, 547–554.
   PubMed Web of Science ®Google Scholar
• Lopez DM, Lopez-Cepero M, Watson GA, Ganju A, Sotomayor E, Fu YX. (1991). Modulation of the immune system by mammary tumor-derived factors. Cancer Invest, 9, 643–653.
   PubMed Web of Science ®Google Scholar
• Malaguarnera L, Ferlito L, Imbesi RM, Gulizia GS, Di Mauro S, Maugeri D, Malaguarnera M, Messina A. (2001). Immunosenescence: a review. Arch Gerontol Geriatr, 32, 1–14.
   Google Scholar
• Miyahira Y, Katae M, Takeda K, Yagita H, Okumura K, Kobayashi S, Takeuchi T, Kamiyama T, Fukuchi Y, Aoki T. (2003). Activation of natural killer T cells by alpha-galactosylceramide impairs DNA vaccine-induced protective immunity against Trypanosoma cruzi. Infect Immun, 71, 1234–1241.
   Google Scholar
• Naser B, Bodinet C, Tegtmeier M, Lindequist U. (2005). Thuja occidentalis (Arbor vitae): A review of its pharmaceutical, pharmacological and clinical properties. Evid Based Complement Alternat Med, 2, 69–78.
   PubMed Web of Science ®Google Scholar
• Neville ME, Robb RJ, Popescu MC. (2001). In situ vaccination against a non-immunogenic tumour using intratumoural injections of liposomal interleukin 2. Cytokine, 16, 239–250.
   PubMed Web of Science ®Google Scholar
• Offergeld R, Reinecker C, Gumz E, Schrum S, Treiber R, Neth RD, Gohla SH. (1992). Mitogenic activity of high molecular polysaccharide fractions isolated from the cuppressaceae Thuja occidentalis L. enhanced cytokine-production by thyapolysaccharide, g-fraction (TPSg). Leukemia, 6 Suppl 3, 189S–191S.
   Google Scholar
• Ozaki K, Leonard WJ. (2002). Cytokine and cytokine receptor pleiotropy and redundancy. J Biol Chem, 277, 29355–29358.
   PubMed Web of Science ®Google Scholar
• Rouhi P, Lee SL, Cao Z, Hedlund EM, Jensen LD, Cao Y. (2010). Pathological angiogenesis facilitates tumor cell dissemination and metastasis. Cell Cycle, 9, 913–917.
   PubMed Web of Science ®Google Scholar
• Singh VK, Agarwal SS, Gupta BM. (1984). Immunomodulatory activity of Panax ginseng extract. Planta Med, 50, 462–465.
   PubMed Web of Science ®Google Scholar
• Tanaka T, Bai Z, Srinoulprasert Y, Yang BG, Yang B, Hayasaka H, Miyasaka M. (2005). Chemokines in tumor progression and metastasis. Cancer Sci, 96, 317–322.
   PubMed Web of Science ®Google Scholar
• Theano T, Pelagia S, Konstantinos N, Petros K, Alfred B, Konstantinos D, Panagiotis G. (2002). Lymphocyte activation by granulocyte macrophage-colony stimulating factor in human bladder cancer. J Exp Ther Oncol, 2, 153–157.
   Google Scholar
• Tsavaris N, Kosmas C, Vadiaka M, Kanelopoulos P, Boulamatsis D. (2002). Immune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes. Br J Cancer, 87, 21–27.
   PubMed Web of Science ®Google Scholar
• Villegas FR, Coca S, Villarrubia VG, Jiménez R, Chillón MJ, Jareño J, Zuil M, Callol L. (2002). Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancer. Lung Cancer, 35, 23–28.
   PubMed Web of Science ®Google Scholar
• Werner GH, Jollès P. (1996). Immunostimulating agents: what next? A review of their present and potential medical applications. Eur J Biochem, 242, 1–19.
   PubMedGoogle Scholar
• Xu HS, Wu YW, Xu SF, Sun HX, Chen FY, Yao L. (2009). Antitumor and immunomodulatory activity of polysaccharides from the roots of Actinidia eriantha. J Ethnopharmacol, 125, 310–317.
   PubMed Web of Science ®Google Scholar